Literature DB >> 22030943

Dimethyl sulfoxide: an effective penetration enhancer for topical administration of NSAIDs.

Karrie Marren1.   

Abstract

Dimethyl sulfoxide (DMSO) is a molecule with a long history in pharmaceutics and is now well established as a penetration enhancer in topical pharmaceutical formulations. It is currently used for this purpose in diclofenac sodium topical solution (approved in the United States to treat signs and symptoms of osteoarthritis) and idoxuridine topical solution (approved in Europe for the treatment of herpes zoster). This article reviews the mechanism of action of DMSO as a pharmaceutical penetration enhancer, the characteristics of the molecule that facilitate transdermal drug delivery, and studies of efficacy and safety. The clinical use of pharmaceutical-grade DMSO as a penetration enhancer is supported by the robust data that have accumulated over the past 3 decades demonstrating the favorable safety and tolerability profile. Dimethyl sulfoxide is a safe and effective mechanism for facilitating the transdermal delivery of both hydrophilic and lipophilic medications to provide localized drug delivery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22030943     DOI: 10.3810/psm.2011.09.1923

Source DB:  PubMed          Journal:  Phys Sportsmed        ISSN: 0091-3847            Impact factor:   2.241


  20 in total

1.  Cytotoxicity of dimethyl sulfoxide (DMSO) in direct contact with odontoblast-like cells.

Authors:  J Hebling; L Bianchi; F G Basso; D L Scheffel; D G Soares; M R O Carrilho; D H Pashley; L Tjäderhane; C A de Souza Costa
Journal:  Dent Mater       Date:  2015-02-10       Impact factor: 5.304

2.  Application of the 3D-RISM-KH molecular solvation theory for DMSO as solvent.

Authors:  Dipankar Roy; Andriy Kovalenko
Journal:  J Comput Aided Mol Des       Date:  2019-10-21       Impact factor: 3.686

3.  Linear Oligosulfoxides: Synthesis and Solubility Studies.

Authors:  Bhaskar Halami; Dhananjani N A M Eriyagama; Komal Chillar; Zack Nelson; Lucas Prehoda; Yipeng Yin; Bao-Yuan Lu; Brett Otto; Liam Haggerty; Shiyue Fang
Journal:  Tetrahedron Lett       Date:  2019-10-22       Impact factor: 2.415

Review 4.  Current Status of Amino Acid-Based Permeation Enhancers in Transdermal Drug Delivery.

Authors:  Rui Pereira; Sandra G Silva; Marina Pinheiro; Salette Reis; M Luísa do Vale
Journal:  Membranes (Basel)       Date:  2021-05-07

5.  A Perspective on Imiquimod Microneedles for Treating Warts.

Authors:  Tsu-Man Chiu; Ping-Chun Hsu; Mohd Yaqub Khan; Cheng-An J Lin; Chun-Hung Lee; Tsai-Ching Hsu; Min-Hua Chen; Nobutaka Hanagata
Journal:  Pharmaceutics       Date:  2021-04-22       Impact factor: 6.321

6.  The effects of chemical and physical penetration enhancers on the percutaneous permeation of lidocaine through equine skin.

Authors:  Jessica Stahl; Manfred Kietzmann
Journal:  BMC Vet Res       Date:  2014-06-20       Impact factor: 2.741

7.  Use of lipolanthionine peptide, a toll-like receptor 2 inhibitor, enhances transdermal delivery efficiency.

Authors:  Bin Chen; Da-Lie Liu; Wen-Yan Pan; Xiao-Hui Yang; Jia-Bao Shou; Ju-Hua Wu; Qing-Long Mao; Jia Wang
Journal:  Mol Med Rep       Date:  2014-05-20       Impact factor: 2.952

Review 8.  Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials.

Authors:  Ibrahim M Abdulbaqi; Yusrida Darwis; Nurzalina Abdul Karim Khan; Reem Abou Assi; Arshad A Khan
Journal:  Int J Nanomedicine       Date:  2016-05-25

9.  Modulation of influenza vaccine immune responses using an epidermal growth factor receptor kinase inhibitor.

Authors:  Joanna A Pulit-Penaloza; Bishu Sapkota; E Stein Esser; Richard W Compans; Brian P Pollack; Ioanna Skountzou
Journal:  Sci Rep       Date:  2015-07-31       Impact factor: 4.379

10.  A prodrug approach to the use of coumarins as potential therapeutics for superficial mycoses.

Authors:  Derry K Mercer; Jennifer Robertson; Kristine Wright; Lorna Miller; Shane Smith; Colin S Stewart; Deborah A O Neil
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.